On this episode of Founder's Sandbox, Brenda McCabe speaks to Christopher Locher, PhD; Co-founder and CEO of Versatope Therapeutics. He previously led drug discovery projects for infectious diseases at Vertex Pharmaceuticals in Boston, inflammatory diseases at Opsona Therapeutics in Ireland and malaria and alphaviruses vaccine development programs at Maxygen in California. Their conversation centers on harnessing the power of nature at scale for good: how and why did Versatope begin, what is deep tech, and how can we build a resilient culture in a pandemic world where the work could not be done “from home?" You can find out more about Christopher and Versatope at: <a href= "https://www.linkedin.com/in/christopher-locher-biotech/"> https://www.linkedin.com/in/christopher-locher-biotech/</a> https://www.versatope.com/ https://news.cornell.edu/stories/2017/09/new-kind-influenza-vaccine-one-shot-might-do-trick

Enrique Serrano: Deep Tech- the Combination of Organic Active Materials and Machines

The Founder’s Sandbox is an exciting podcast produced and sponsored by Next Act Advisors. Our host and founder of NAA, Brenda McCabe, will be interviewing players in the ecosystem of startups. Discussion centers on the nuts and bolts of resilient companies, shared experiences creating (and keeping) revenue, while making companies playful AND well governed! We tackle common issues faced by the founders of startups, and talk about how to create a fun environment where, under great corporate governance, founders can sit back and watch their employees build and play.
Show intro music written and recorded by Daphne Willis, artwork and graphics by Whitney Otte. All shows hosted by Brenda McCabe.
You can find out more about NAA and Brenda McCabe at https://nextactadvisors.com